ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,048.42
      -0.46%
      US Tech 100
      17,141.20
      0.96%
      Dow Jones
      38,085.80
      -0.98%
      Brent Oil
      88.41
      0.29%
      Bitcoin
      64,192.27
      -0.45%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Aim Immunotech Inc (0A4Y)

      7. Aim Immunotech Inc (0A4Y) News

      0A4Y Aim Immunotech Inc

      0.00
      0.00 (0.00%)
      Last Updated: -
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Aim Immunotech Inc 0A4Y London Ordinary Share
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% -
      Open Price Low Price High Price Close Price Prev Close
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      4/10/202408:21UKREGAIM ImmunoTech Announces Positive Top-Line, Protocol-Planned..
      4/02/202407:30UKREGAIM ImmunoTech Reports Fourth Quarter and Full Year 2023..
      3/26/202409:05UKREGAIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023..
      3/25/202409:05UKREGAIM ImmunoTech Announces Publication of Positive Findings..
      3/07/202408:45UKREGAIM ImmunoTech Announces Launch of CEO Corner Platform
      2/29/202408:45UKREGAIM ImmunoTech Outlines Recent Progress Across Clinical..
      2/14/202408:55UKREGAIM ImmunoTech Announces First Subject Dosed in the..
      1/24/202409:10GLOBEAIM ImmunoTech Receives Erasmus Medical Center Ethics Board..
      1/22/202408:55GLOBEAIM ImmunoTech Announces that the First Subject is Enrolled..
      1/10/202408:45GLOBEAIM ImmunoTech Announces Open Enrollment for Phase 1b/2..
      11/27/202309:05GLOBEAIM ImmunoTech Bolsters Intellectual Property Estate for..
      11/15/202307:30GLOBEAIM ImmunoTech Reports Third Quarter 2023 Financial Results..
      11/09/202308:05GLOBEAIM ImmunoTech to Discuss Third Quarter 2023 Financial..
      10/17/202308:45GLOBEAIM ImmunoTech Engages Business Development Firm, Azenova,..
      9/11/202313:00GLOBEAIM ImmunoTech Announces Report of Complete Topline Data..
      8/15/202306:45GLOBEAIM ImmunoTech Reports Second Quarter Financial Results and..
      8/09/202309:05GLOBEAIM ImmunoTech to Discuss Second Quarter 2023 Financial..
      8/08/202308:05GLOBEAIM ImmunoTech Announces Completion of Enrollment in Phase 2..
      7/18/202319:30GLOBEAIM ImmunoTech Issues Notice that an Unaffiliated Third..
      7/10/202308:05GLOBEAIM ImmunoTech Enrolls and Doses First Subject in Phase 2..
      6/27/202311:16GLOBEAIM ImmunoTech Announces Publication of Positive Findings..
      6/27/202308:45GLOBEAIM ImmunoTech Announces Authorizations from Competent..

      Your Recent History

      LSE
      0A4Y
      Aim Immunotech
      Delayed Upgrade Clock